Home / Inspections / 1235495

FDA Inspection 1235495 — Novel Laboratories, Inc. d.b.a Lupin Somerset

Novel Laboratories, Inc. d.b.a Lupin Somerset — FEI 3006271438

The FDA completed an inspection of Novel Laboratories, Inc. d.b.a Lupin Somerset on May 17, 2024 in Somerset, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 17, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Somerset, NJ (United States)

Facility

Other inspections at this facility

  • 1306616 (VAI Fri Apr 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1285934 (VAI Fri Oct 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1197049 (VAI Fri Jan 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1168160 (VAI Wed Mar 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1133661 (OAI Thu Nov 05 2020 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources